Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 2022; Volume 382,Issue 1

Behavioral Pharmacology

  • You have access
    Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice
    Edna J. Santos, Matthew L. Banks and S. Stevens Negus
    Journal of Pharmacology and Experimental Therapeutics July 2022, 382 (1) 44-53; DOI: https://doi.org/10.1124/jpet.121.001045
  • You have access
    Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence
    R.A. Gray, D.J. Heal, D.R. Maguire, L.R. Gerak, M.A. Javors, S. Smith and C.P. France
    Journal of Pharmacology and Experimental Therapeutics July 2022, 382 (1) 54-65; DOI: https://doi.org/10.1124/jpet.121.000988

Cardiovascular

  • You have access
    Optimized S-nitrosohemoglobin Synthesis in Red Blood Cells to Preserve Hypoxic Vasodilation Via βCys93
    Alfred Hausladen, Zhaoxia Qian, Rongli Zhang, Richard T. Premont and Jonathan S. Stamler
    Journal of Pharmacology and Experimental Therapeutics July 2022, 382 (1) 1-10; DOI: https://doi.org/10.1124/jpet.122.001194

Chemotherapy, Antibiotics, and Gene Therapy

  • You have access
    Sodium Pentobarbital Suppresses Breast Cancer Cell Growth Partly via Normalizing Microcirculatory Hemodynamics and Oxygenation in Tumors
    Qin Wang, Xueting Liu, Bingwei Li, Xiaojie Yang, Wenbao Lu, Ailing Li, Hongwei Li, Xiaoyan Zhang and Jianqun Han
    Journal of Pharmacology and Experimental Therapeutics July 2022, 382 (1) 11-20; DOI: https://doi.org/10.1124/jpet.121.001058

Drug Discovery and Translational Medicine

  • You have access
    Treatment of γ-Hydroxybutyrate Overdose with the GABAB Antagonist SGS742
    Kristin E. Follman and Marilyn E. Morris
    Journal of Pharmacology and Experimental Therapeutics July 2022, 382 (1) 21-30; DOI: https://doi.org/10.1124/jpet.122.001108
  • You have access
    Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic Progenitors
    Xiaoqing Fan, Wojciech Krzyzanski, Raymond S.M. Wong and Xiaoyu Yan
    Journal of Pharmacology and Experimental Therapeutics July 2022, 382 (1) 31-43; DOI: https://doi.org/10.1124/jpet.122.001130
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 382 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 382, Issue 1
1 Jul 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Behavioral Pharmacology
  • Cardiovascular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Nose-to-Brain Delivery
  • Antipsychotic-VMAT2 Inhibitor Synergy: Schizophrenia Models
  • SEP-363856, a Novel, Non-D2 Psychotropic Agent
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics